Weekly Winners | Kenvue, Datadog, Expedia Soar 17%; Incyte, Expeditors Surge 13%; Marriott Jumps 12%

Tiger Newspress
11/09

This week, which stocks lagged or dragged? Weekly Winners column keeps up with market trends, helping Tigers sort out the week's hottest sectors, stock winners and important news.

Below are top 10 S&P 500 stock gainers for the week ended Nov. 7:

Kimberly-Clark Agrees to Buy Tylenol Owner Kenvue in $48.7 Billion Deal, Creating Consumer Staples Giant

Kimberly-Clark announced Monday it’s struck an agreement to buy Kenvue Inc in a deal valued at $48.7 billion that would create a consumer staples giant.

The deal is a combination of cash and stock and totals about $40 billion on an equity basis, excluding the impact of debt. Shares of Kenvue surged 12% Monday, while Kimberly-Clark stock fell 14%.

The combined company would bring together brands like Huggies and Kleenex with the likes of Band-Aid and Tylenol. It would include 10 billion-dollar brands, the companies said in a news release. The acquisition would be one of the largest on Wall Street this year.

Datadog's Stock Soars on Revenue Beat, Posts Second-Best Day Ever

Datadog shares jumped 23% on Thursday after the software company reported third-quarter revenue that topped Wall Street estimates and issued a strong forecast for the fourth quarter.

The stock had its second-best day ever, behind only November 2023, when shares rose 28%.

The company reported revenue of $885.7 million, which was up 28% year over year, and topped the $852.8 million expected by LSEG analysts.

Expedia Stock Jumps. High Travel Demand Powers Stronger-Than-Expected Q3 Results

Expedia stock jumped late Thursday after the online travel booking company posted a third-quarter earnings beat and offered a strong sales forecast for the final three months of the year.

Expedia said that it earned an adjusted $7.57 per share for the September-ended quarter, up 23% from a year earlier. That beat the $6.97 per share that analysts polled by FactSet were forecasting. Sales increased 9% to $4.41 billion compared to analyst estimates of $4.28 billion.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10